Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are observing adults with Chronic Rhinosinusitis With Nasal Polyps CRSwNP, with or without asthma, who have recently started treatment with tezepelumab. This observational study collects data from real-world clinical settings in Russia to understand how tezepelumab is used and its effects outside of controlled trials. The study includes about 110 adults treated according to their doctors prescriptions. Participants have initiated tezepelumab treatment no more than 4 weeks before joining the study. This non-interventional study gathers information from medical records and primary data over a year, focusing on changes in nasal polyp status and nasal congestion. The study is conducted at approximately 10 sites, following patients for up to 52 weeks after starting tezepelumab. During the study, participants medical records will be reviewed, and assessments including nasal endoscopy, nasal blockage scoring, and symptom questionnaires like SNOT-22 will be collected at baseline and at weeks 4, 24, and 52. Researchers will also evaluate healthcare use related to CRSwNP and asthma and monitor treatment duration and discontinuation. The study aims to provide comprehensive real-world data on tezepelumabs use and patient outcomes over one year.